pISSN 3022-6783
eISSN 3022-7712

View

Article View

Korean J Transplant 2022; 36(4): 259-266

Published online December 31, 2022

https://doi.org/10.4285/kjt.22.0039

© The Korean Society for Transplantation

Impact of the preoperative skeletal muscle index on early remnant liver regeneration in living donors after liver transplantation

Sunyoung Lee1 , Kyoung Won Kim2 , Heon-Ju Kwon3 , Jeongjin Lee4 , Gi-Won Song5 , Sung-Gyu Lee5

1Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
3Department of Radiology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
4School of Computer Science and Engineering, Soongsil University, Seoul, Korea
5Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Correspondence to: Kyoung Won Kim
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro, 43-gil, Songpa-gu, Seoul 05505, Korea
Tel: +82-2-3010-4400
Fax: +82-2-476-4719
E-mail: kimkw@amc.seoul.kr

Sunyoung Lee
Department of Radiology and Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-2228-7400
Fax: +82-2-2227-8337
E-mail: carnival0126@gmail.com

Received: August 19, 2022; Revised: September 11, 2022; Accepted: September 28, 2022

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Background: We investigated the correlation between the preoperative skeletal muscle index (SMI) and remnant liver regeneration after right hemihepatectomy for living-donor liver transplantation and aimed to identify preoperative predictors of greater early remnant liver regeneration in living donors.
Methods: This retrospective study included 525 right hemiliver donors (mean age, 28.9±8.3 years; 345 male patients) between 2017 and 2018, who underwent computed tomography before surgery and on postoperative day (POD) 7. Preoperative anthropometry, laboratory parameters, skeletal muscle area at the third lumbar vertebral level, and liver volume before and after surgery were evaluated. Correlations were analyzed using Pearson correlation coefficients, and stepwise multiple regression analysis was performed to identify independent predictors of greater remnant liver regeneration.
Results: Remnant liver regeneration volume on POD 7 was positively correlated with body mass index (BMI; r=0.280, P<0.001) and SMI (r=0.322, P<0.001), and negatively correlated with age (r=–0.154, P<0.001) and the ratio of future remnant liver volume (FRLV) to total liver volume (TLV; r=–0.261, P<0.001). Stepwise multiple regression analysis showed that high BMI (β=0.146; P=0.001) and SMI (β=0.228, P<0.001), young age (β=–0.091, P=0.025), and a low FRLV/TLV ratio (β=–0.225, P<0.001) were predictors of greater remnant liver regeneration.
Conclusions: High SMI and BMI, young age, and a low FRLV/TLV ratio may predict greater early remnant liver regeneration in living donors after LDLT.

Keywords: Liver transplantation, Living donors, Computed tomography volumetry, Liver regeneration, Skeletal muscle index

HIGHLIGHTS
  • The remnant liver regeneration volume on postoperative day (POD) 7 was positively correlated with the body mass index (BMI) and skeletal muscle index (SMI).

  • The remnant liver regeneration volume on POD 7 was negatively correlated with age and the ratio of future remnant liver volume (FRLV) to total liver volume (TLV).

  • High SMI and BMI, young age, and a low FRLV/TLV ratio in living donors may be predictors of greater early remnant liver regeneration after living-donor liver transplantation.

Liver transplantation (LT) is considered the most effective treatment for end-stage liver disease [1], and living-donor LT (LDLT) has been increasingly performed due to a shortage of liver grafts from deceased donors [2]. LDLT is performed based on the assumption that the liver has a rapid and abundant regenerative capacity [3]. In adult LDLT, liver regeneration is a crucial process to ensure donor safety and avoid hepatic dysfunction in recipients [4]. The success of LDLT depends on the capacity for remnant and graft liver regeneration in donors and recipients, respectively [5]. Studies have demonstrated that early liver regeneration occurs with a peak in DNA synthesis around postoperative day (POD) 7–10, and that future liver remnant regeneration has the strongest potential within 7 days after surgery [3,6]. Previous studies have suggested that presurgical factors including age, body mass index (BMI), and future remnant liver volume (FRLV) may influence liver regeneration [7,8].

It is well known that sarcopenia, defined as a reduction of skeletal muscle mass, is a clinical feature of metabolic dysfunction related to end-stage liver disease, and skeletal muscle mass has been found to be an important predictor of LT outcomes in recipients [9]. Additionally, a previous study reported that skeletal muscle mass, as measured on preoperative computed tomography (CT), had a significant positive correlation with the graft regeneration rate in LT recipients, and that low pretransplant skeletal muscle mass was associated with impaired graft regeneration after LDLT [10]. However, to the best of our knowledge, the association between skeletal muscle mass and remnant liver regeneration volume has not been studied in living donors.

Therefore, the purpose of the present study was to investigate the correlation between the preoperative skeletal muscle index (SMI) and remnant liver regeneration in living donors 7 days after right hemihepatectomy for LDLT, and to identify preoperative predictors of greater early remnant liver regeneration.

This retrospective study was approved by the Institutional Review Board of Asan Medical Center (IRB No. S2021-2223), which waived the requirement for informed consent.

Study Population

We retrospectively searched the LT database and identified 654 live donors who underwent right hemihepatectomy for LDLT between January 2017 and December 2018 at Asan Medical Center. The donors underwent CT of the liver as part of the preoperative work-up for the evaluation of anatomical variations in the hepatic vasculature and the estimation of liver volume, and postoperative CT at or around POD 7 to screen for complications and evaluate remnant liver regeneration. We excluded 129 subjects in whom the time between LT surgery and postoperative CT was shorter or longer than 7 days.

Computed Tomography Acquisition

Preoperative CT scans were performed using 64-slice (SOMATOM Definition; Siemens, Erlangen, Germany) or 128-slice (SOMATOM Definition AS+ or SOMATOM Definition Edge, Siemens) multidetector scanners. Unenhanced CT scans were obtained, followed by biphasic (hepatic arterial and portal venous phases) contrast-enhanced scans after the administration of 150 mL of iopromide (Ultravist 370, Bayer HealthCare, Berlin, Germany) for the anatomical mapping of the hepatic vasculature and CT volumetry. The scanning parameters were as follows: beam collimation of 64 or 128 slices by 0.6 mm; spiral pitch of 1; gantry rotation time of 0.5 seconds; 200 effective mAs with automatic exposure control (Care Dose 4D, Siemens); and 100 kVp. Images were reconstructed using a section thickness of 5 mm at 5-mm intervals. Postoperative CT scans for the screening of surgical complications and evaluation of remnant liver regeneration in living liver donors were obtained using monophasic (portal venous phase) contrast-enhanced CT with an ultra-low-dose protocol (40 effective mAs and 100 kVp). The other parameters were the same as those used for the preoperative scans.

Computed Tomography Volumetry

A semi-automated volumetric analysis of the donor liver was performed on CT images prior to surgery and on POD 7 using computer-aided in-house liver volumetry software. Volume measurements were performed by a board-certified abdominal radiologist (KWK) with 20 years of experience in hepatobiliary imaging. The preoperative volumetric analysis was performed sequentially in three steps. First, the initial liver outline was detected through sequential application of seeded region growing onto level-set speed images, which were generated as a map inversely proportional to the gradient magnitude [11]. Second, the level-set method was used to perform liver segmentation based on the initially detected liver contour [11], with Malladi’s level-set method being used for the level-set propagation [12]. After the manual correction of mis-segmentation, if any, the total liver volume (TLV) was obtained. Third, and finally, the radiologist repeatedly defined a resection line dividing the liver into the right hemiliver and the left hemiliver plus segment 1 on a few representative slices based on Cantlie's line or the long axis of the middle hepatic vein. FRLV was defined as the volumetric sum of the left hemiliver plus segment 1 under the assumption of right hemiliver donation [8]. The postoperative liver volume analysis was performed using the same techniques described above, except there was no need for the final step. The remnant liver regeneration volume on POD 7 was calculated by subtracting the FRLV measured on the preoperative CT from the remnant liver volume measured on the POD 7 CT.

Skeletal Muscle Measurement

A single axial preoperative CT image at the level of the inferior endplate of the third lumbar vertebra was processed for each patient. Abdominal CT image analyses were performed with a fully convolutional, network-based, automatic segmentation technique using a deep-learning system [13]. The skeletal muscle was assessed using artificial intelligence software (AID-U; iAID Inc., Seoul, Korea) [13]. CT images were automatically segmented to generate boundaries, and the total abdominal muscle area was measured. The skeletal muscle area (SMA; cm2), including all muscles on the selected axial image (i.e., psoas, paraspinal, transversus abdominis, rectus abdominis, quadratus lumborum, and internal and external oblique muscles) was demarcated using predetermined thresholds (–29 to 150 Hounsfield units). The SMI was normalized to stature by dividing the muscle area by the height squared, as follows: SMA (cm2)/height (m2).

Data Collection

Preoperative anthropometric measurements (body weight and height) and laboratory parameters (platelet count, prothrombin time, and serum levels of aspartate aminotransferase, alanine aminotransferase, total bilirubin, and albumin) were collected preoperatively. BMI was calculated as body weight (kg) divided by the square of the height (m2). Perioperative findings included operation time and blood loss. Information on the hospital stay duration and complications after donor hepatectomy was collected postoperatively.

Statistical Analysis

Continuous variables were expressed as mean±standard deviation, and categorical variables were expressed as frequencies with percentages. Correlations between remnant liver regeneration volume on POD 7 and other variables were analyzed using Pearson correlation coefficients. Stepwise multiple regression analysis was performed using the backward selection method, including all significant variables from the aforementioned analysis. Statistical significance was set at P<0.05, and statistical analyses were performed using IBM SPSS ver. 23 (IBM Corp., Armonk, NY, USA).

Characteristics of the Study Population

A total of 525 donors (mean age, 28.9±8.3 years; 345 men and 180 women) were included in the analysis. The characteristics of the study population are summarized in Table 1. The mean FRLV, TLV, and FRLV-to-TLV ratio (FRLV/TLV) on preoperative CT images were 412.1±96.3 cm3, 1,164.5±239.4 cm3, and 35.3%±3.6%, respectively. The remnant liver regeneration volume on POD 7 CT images was 374.2±117.3 cm3. The mean SMI on preoperative CT images was 48.2±8.9 cm2.

Table 1. Characteristics of the study population

CharacteristicValue (n=525)
Demographic variable
Age (yr)28.9±8.3
Male sex345 (65.7)
Anthropometric parameter
Body mass index (kg/m2)23.4±3.0
Laboratory data
Platelet count (×109/L)259.5±53.6
Prothrombin time (INR)1.04±0.24
AST (IU/L)21.8±18.1
ALT (IU/L)21.1±20.4
Total bilirubin (mg/dL)0.7±0.5
Albumin (g/dL)4.2±0.3
Liver volume measured by CT volumetry
FRLV (cm3)412.1±96.3
TLV (cm3)1,164±239.4
FRLV/TLV ratio (%)35.3±3.6
Remnant liver regeneration volume on POD 7 (cm3)374.2±117.3
Skeletal muscle index (cm2/m2)48.2±8.9
Operation time (hr)6.0±0.9
Blood loss (mL)
<10253 (48.2)
10–100262 (49.9)
>10010 (1.9)
Hospital stay duration (day)11.7±1.9

Values are presented as mean±standard deviation or number (%).

INR, international normalized ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase; CT, computed tomography; FRLV, future remnant liver volume; TLV, total liver volume; POD, postoperative day.



Correlation between Regenerated Liver Volume and Clinical Parameters

The remnant liver regeneration volume on POD 7 CT images was positively correlated with BMI (r=0.280, P<0.001), alanine aminotransferase (r=0.137, P=0.002), and SMI (r=0.322, P<0.001), and negatively correlated with age (r=–0.154, P<0.001) and the FRLV/TLV ratio (r=–0.261, P<0.001) (Table 2).

Table 2. Correlation between preoperative variables and remnant liver regeneration volume on POD 7

VariableRemnant liver regeneration volume on POD 7 (cm3)

Correlation coefficient (r)P-value
Age (yr)–0.154<0.001a)
Body mass index (kg/m2)0.280<0.001a)
Platelet count (×109/L)0.0530.354
Prothrombin time (INR)0.0470.442
AST (IU/L)0.0670.125
ALT (IU/L)0.1370.002a)
Total bilirubin (mg/dL)0.0610.166
Albumin (g/dL)0.0810.065
FRLV/TLV ratio (%)–0.261<0.001a)
Skeletal muscle index (cm2/m2)0.322<0.001a)

POD, postoperative day; INR, international normalized ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase; FRLV, future remnant liver volume; TLV, total liver volume.

a)Statistically significant results from Pearson correlation coefficient analysis.



Preoperative Predictors of Remnant Liver Regeneration

Stepwise multiple regression analysis showed that a high BMI (β=0.146, P=0.001), high SMI (β=0.228, P<0.001), young age (β=−0.091, P=0.025) and low FRLV/TLV ratio (β=−0.225, P<0.001) were predictors of greater remnant liver regeneration volume at POD 7 (Table 3, Fig. 1).

Table 3. Preoperative factors predictive of remnant liver regeneration volume on POD 7 by multiple regression analysis

VariableRemnant liver regeneration volume on POD 7 (cm3)

BStandard errorβ coefficientP-value
Age (yr)–1.2800.568–0.0910.025
Body mass index (kg/m2)5.6861.7420.1460.001
FRLV/TLV ratio (%)–7.3551.304–0.225<0.001
Skeletal muscle index (cm2/m2)2.9870.5940.228<0.001

POD, postoperative day; FRLV, future remnant liver volume; TLV, total liver volume.


Figure 1. Relationships between remnant liver regeneration volume on postoperative day (POD) 7 and preoperative variables, including age (A), body mass index (BMI; B), future remnant liver volume to total liver volume (FRLV/TLV) ratio (C), and skeletal muscle index (SMI; D) in living liver donors after right hemihepatectomy.

Perioperative and Postoperative Outcomes of Living Donors

The remnant liver regeneration volume on POD 7 was not significantly correlated with the operation time (r=0.008, P=0.851), blood loss (r=0.042, P=0.335), or length of hospital stay (r=–0.017, P=0.699). None of the donors experienced post-hepatectomy hepatic failure or postoperative complications.

In the present study, the early remnant liver regeneration at POD 7 of LT donors after right hemihepatectomy showed significant negative correlations with age and the FRLV/TLV ratio, while it was positively correlated with preoperative BMI and SMI. Additionally, the results of the present study indicated that high BMI and SMI, young age, and a low FRLV/TLV ratio were significant predictors of greater early remnant liver regeneration in living donors after LT.

Several studies have shown that advanced donor age may have a significant negative influence on early graft regeneration in LDLT recipients [7,10,14]. In a previous study by Ikegami et al. [14], early graft regeneration was significantly lower at POD 7 in older donors (≥50 years) than in younger donors (<30 years), in which an extended left hemiliver graft was used. Pravisani et al. [10] also reported that donor age showed a significant negative correlation with the graft regeneration rate in LDLT patients who received an extended left hemiliver graft. Additionally, Tanemura et al. [7] identified that donor age (≥50 years) was an independent factor correlated with impaired graft regeneration at POD 7 in both right and left hemiliver LDLT recipients. Meanwhile, the effects of donor age on remnant liver regeneration in living liver donors remains undetermined. Previous studies did not show significant differences in remnant liver regeneration volumes between younger and older donor groups [15,16]. However, Ono et al. [17] revealed that the remnant liver regeneration rate at POD 7 in living donors was impaired with increased age, especially after right hemihepatectomy. Similarly, the results of the present study showed that the remnant liver regeneration volume at POD 7 after right hemihepatectomy was negatively correlated with age in living donors. Aging is accompanied by a gradual decline in the regenerative capacity of hepatocytes, with a decrease in the cell cycle and an increase in autophagy and apoptosis [3].

In the present study, the remnant liver regeneration volume in LDLT donors after right hemihepatectomy showed a negative correlation with the preoperatively estimated FRLV/TLV ratio. This result is consistent with a previous study in Japan that included living donors who underwent left lateral sectionectomy or left hemihepatectomy [18]. In previous studies, lower FRLV or FRLV/TLV ratio were independent predictors of greater liver regeneration in living donors [4,8]. The results of the present study also demonstrated that a lower FRLV/TLV ratio was a positive predictor of early remnant liver regeneration after LDLT. The release of proinflammatory cytokines, such as interleukin-6 or tumor necrosis factor-α, initiates the regenerative process after resection [3,8]. Larger hepatic resections may lead to a greater concentration of cytokines, thereby promoting greater remnant liver regeneration [3,8]. Additionally, Gruttadauria et al. [8] reported that higher BMI was a predictor of greater remnant liver regeneration in living donors after right hemihepatectomy, which is in line with the results of the present study.

A limited number of studies have evaluated the influence of pretransplant skeletal muscle mass on liver grafts after LDLT [10,19]. Pravisani et al. [10] evaluated the correlation between recipients’ pretransplant skeletal muscle mass and liver graft regeneration in left hemiliver LDLT. In that study, decreased skeletal muscle mass was associated with a significantly lower graft regeneration rate in both sexes, and recipients’ pretransplant skeletal muscle indices showed a significant positive correlation with graft regeneration rates at 1 month after LDLT in men [10]. Miyachi et al. [19] investigated the effect of donors’ skeletal muscle mass and quality on recipients’ graft survival after LDLT. They found that high muscle mass and quality in male donors were independent protective factors for graft loss in recipients [19]. Unlike these previous studies, the present study focused on the association of donors’ preoperative skeletal muscle mass with remnant liver regeneration after right hemihepatectomy for LDLT. The results of the present study demonstrated a significant positive correlation between preoperative SMI and remnant liver regeneration, and identified high SMI as a significant predictor of early remnant liver regeneration in LT donors.

The present study has several limitations. First, this was a single-center retrospective study, and the results need to be prospectively validated in a multicenter trial. Second, because of the ethnic homogeneity of Koreans, the impact of race on remnant liver regeneration after LT remains unclear. Third, we did not evaluate muscle quality or strength. Because sarcopenia is defined as low muscle strength and low muscle quantity or quality [20], we could not analyze the relationship between the presence of sarcopenia and liver regeneration. Further studies may be required to assess the associations of muscle quality, muscle strength, and sarcopenia with liver regeneration. Fourth, since the present study focused on early remnant liver regeneration in donors after LDLT, we did not evaluate graft liver regeneration or graft survival outcomes in LT recipients.

In conclusion, high SMI and BMI, young age, and a low FRLV/TLV ratio may be predictors of greater early remnant liver regeneration in living donors after LDLT.

Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Funding/Support

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT and Future Planning (No. 2017R1E1A1A03070961). This study was also supported by research grant from the Korean Society for Transplantation (2022-00-01001-017).

Author Contributions

Conceptualization: SL, KWK. Data curation: SL, KWK, HJK, JL. Formal analysis: SL. Funding acquisition: KWK. Investigation: SL, GWS, SGL. Methodology: SL, KWK. Project administration: SL, KWK. Visualization: SL, KWK. Writing–original draft: SL, KWK. Writing–review & editing: SL, KWK.

  1. European Association for the Study of the Liver. EASL clinical practice guidelines: liver transplantation. J Hepatol 2016;64:433-85.
    Pubmed CrossRef
  2. Lee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant 2015;15:17-38.
    Pubmed CrossRef
  3. Yagi S, Hirata M, Miyachi Y, Uemoto S. Liver regeneration after hepatectomy and partial liver transplantation. Int J Mol Sci 2020;21:8414.
    Pubmed KoreaMed CrossRef
  4. Olthoff KM, Emond JC, Shearon TH, Everson G, Baker TB, Fisher RA, et al. Liver regeneration after living donor transplantation: adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2015;21:79-88.
    Pubmed KoreaMed CrossRef
  5. Haga J, Shimazu M, Wakabayashi G, Tanabe M, Kawachi S, Fuchimoto Y, et al. Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transpl 2008;14:1718-24.
    Pubmed CrossRef
  6. Zappa M, Dondero F, Sibert A, Vullierme MP, Belghiti J, Vilgrain V. Liver regeneration at day 7 after right hepatectomy: global and segmental volumetric analysis by using CT. Radiology 2009;252:426-32.
    Pubmed CrossRef
  7. Tanemura A, Mizuno S, Wada H, Yamada T, Nobori T, Isaji S. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J Surg 2012;36:1102-11.
    Pubmed CrossRef
  8. Gruttadauria S, Parikh V, Pagano D, Tuzzolino F, Cintorino D, Miraglia R, et al. Early regeneration of the remnant liver volume after right hepatectomy for living donation: a multiple regression analysis. Liver Transpl 2012;18:907-13.
    Pubmed CrossRef
  9. Carey EJ, Lai JC, Sonnenday C, Tapper EB, Tandon P, Duarte-Rojo A, et al. A North American expert opinion statement on sarcopenia in liver transplantation. Hepatology 2019;70:1816-29.
    Pubmed KoreaMed CrossRef
  10. Pravisani R, Soyama A, Ono S, Baccarani U, Isola M, Takatsuki M, et al. Is there any correlation between liver graft regeneration and recipient's pretransplant skeletal muscle mass? A study in extended left lobe graft living-donor liver transplantation. Hepatobiliary Surg Nutr 2020;9:183-94.
    Pubmed KoreaMed CrossRef
  11. Lee J, Kim N, Lee H, Seo JB, Won HJ, Shin YM, et al. Efficient liver segmentation using a level-set method with optimal detection of the initial liver boundary from level-set speed images. Comput Methods Programs Biomed 2007;88:26-38.
    Pubmed CrossRef
  12. Malladi R, Sethian JA, Vemuri BC. Shape modeling with front propagation: a level set approach. IEEE Trans Pattern Anal Mach Intell 1995;17:158-75.
    CrossRef
  13. Park HJ, Shin Y, Park J, Kim H, Lee IS, Seo DW, et al. Development and validation of a deep learning system for segmentation of abdominal muscle and fat on computed tomography. Korean J Radiol 2020;21:88-100.
    Pubmed KoreaMed CrossRef
  14. Ikegami T, Nishizaki T, Yanaga K, Shimada M, Kishikawa K, Nomoto K, et al. The impact of donor age on living donor liver transplantation. Transplantation 2000;70:1703-7.
    Pubmed CrossRef
  15. Kwon KH, Kim YW, Kim SI, Kim KS, Lee WJ, Choi JS. Postoperative liver regeneration and complication in live liver donor after partial hepatectomy for living donor liver transplantation. Yonsei Med J 2003;44:1069-77.
    Pubmed CrossRef
  16. Kim SJ, Kim DG, Chung ES, Lee YJ, Moon IS, Lee MD. Adult living donor liver transplantation using the right lobe. Transplant Proc 2006;38:2117-20.
    Pubmed CrossRef
  17. Ono Y, Kawachi S, Hayashida T, Wakui M, Tanabe M, Itano O, et al. The influence of donor age on liver regeneration and hepatic progenitor cell populations. Surgery 2011;150:154-61.
    Pubmed CrossRef
  18. Nakagami M, Morimoto T, Itoh K, Arima Y, Yamamoto Y, Ikai I, et al. Patterns of restoration of remnant liver volume after graft harvesting in donors for living related liver transplantation. Transplant Proc 1998;30:195-9.
    Pubmed CrossRef
  19. Miyachi Y, Kaido T, Hirata M, Iwamura S, Yao S, Shirai H, et al. The combination of a male donor's high muscle mass and quality is an independent protective factor for graft loss after living donor liver transplantation. Am J Transplant 2020;20:3401-12.
    Pubmed CrossRef
  20. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48:16-31.
    Pubmed KoreaMed CrossRef